Elena Masselli: Can Statins Enhance Peginterferon Therapy in MPNs?
Elena Masselli, Full Professor of Human Anatomy at the University of Parma and Consultant Hematologist at the University Hospital of Parma, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Advances, adding:
“Thrilled to share our commentary recently published in Blood Advances on the paper by Professor Hans Hasselbalch’s group exploring the clinically relevant synergy between peginterferon and statins in patients with myeloproliferative neoplasms.
Our article discusses the signalling pathways that may contribute to the synergistic effects of these treatments.
We are truly honoured to have received such positive feedback from the authors!
Take a look and let us know your thoughts!”
Title: Are statins interferon’s best friend? Mechanistic insights
Authors: Giacomo Maria Cerreto, Cecilia Carubbi, Marco Vitale, Elena Masselli
Stay updated with Hemostasis Today.
-
Sep 8, 2026, 02:49Jared Rice: High Platelets, Low Clot Risk? – What Makes Neonatal Platelets Different in Sepsis
-
Sep 8, 2026, 02:46Rasha E.: Exploring Polycythemia Vera: Beyond the Hematocrit
-
Sep 8, 2026, 02:35Ahmet Davut Aksu: Plasminogen Supplementation Enhances Alteplase Efficacy in Systemic Embolization Model
-
Sep 7, 2026, 23:56Abdel Gaffar Mohammed: Treatment Approaches for Different Types of TMA
-
Sep 7, 2026, 18:36Richard Kollen: Preventing Deep Vein Thrombosis During Long Flights
-
Sep 7, 2026, 18:34Mahmoud Hashem: Apixaban – Doses According to the Reason for Use
-
Sep 7, 2026, 18:31Julian P. Villacastin: LAAC as a Treatment Option When Long-Term Anticoagulation Is Problematic
-
Sep 7, 2026, 18:29Geoff Stooke: How Hemophilia Led the Massie Family to the Romanovs and Ronald Reagan
-
Sep 7, 2026, 18:27Sam Mbunya: September is Sickle Cell Awareness Month